Devapriya Sinha

About

Devapriya Sinha is a highly motivated researcher, with rich experience in enzymology, antibacterial drug discovery and method development for HTS.
She is specialized in biochemistry and microbiology with technical expertise in molecular biology, cell biology & biophysical techniques.
Her interest is in translational research and drug development.

Employment

• University of Washington Senior fellow
  2017 - Present
• Beckman Research Institute

Education

• University of Delhi Ph.D.
  2012 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Rapid, direct detection of bacterial topoisomerase 1-DNA adducts by RADAR/ELISA
  Analytical Biochemistry 2020 DOI: 10.1016/j.ab.2020.113827
  +Save
• Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase ia and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
  2019
  +Save
• Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.
  Scientific reports 2017 DOI: 10.1038/srep44419
  +Save
• Naphthalenediimide-Linked Bisbenzimidazole Derivatives as Telomeric G-Quadruplex-Stabilizing Ligands with Improved Anticancer Activity.
  ACS omega 2017 DOI: 10.1021/acsomega.6b00523
  +Save
• Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
  Bioorganic chemistry 2016 DOI: 10.1016/j.bioorg.2016.10.001
  +Save
• Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.
  Journal of medicinal chemistry 2014 DOI: 10.1021/jm5003028
  +Save
• 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.
  The Journal of antimicrobial chemotherapy 2012 DOI: 10.1093/jac/dks322
  +Save